Role of GAB glutaminase in glioblastoma.
2021/41/B/NZ5/01883
Keywords
Descriptors
- NZ5_003: Patogeneza chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN
Voivodeship: mazowieckie
Principal investigator (from the host institution)
dr hab. Monika Paulina Szeliga
Number of co-investigators in the project: 6
Call
OPUS 21 – announced on 2021-03-15
- Amount awarded
- 1 860 960 PLN
- Project start date
- 2022-01-17
- Project end date
- 2027-01-16
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Two Faces of Glutaminase GLS2 in Carcinogenesis.
- Authors:
- Buczkowska Joanna, Szeliga Monika
- Academic press:
- Cancers (year: 2023, volume: 15, pages: 5566), Publisher: mdpi
- Status:
- Published
- DOI:
- 10.3390/cancers15235566 – link to the publication